Telomeric 1p36.3 deletion and Ki-67 expression in B-Non-Hodgkin's Lymphoma patients associated with chronic hepatitis C virus infection

Journal of Viral Hepatitis

Volumn 21, Issue 12, 2014, Pages 950-955

  Mosad, E ^a   Said Abd El Rahman Allam, M ^b   Moustafa, H M ^c   Mohammed, A Eliaw ^b   El Kebeer, A M ^c   Abdel Moneim, S S ^d  

^a Assiut University Faculty of Medicine   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

^c AL AZHAR UNIVERSITY   (Egypt)

^d ASSIUT UNIVERSITY   (Egypt)

Author keywords

1p36.3 deletion; B Non Hodgkin's lymphoma; hepatitis C virus; Ki 67 expression

Indexed keywords

KI 67 ANTIGEN;

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER PATIENT; CANCER SURVIVAL; CHROMOSOME 1P; CHROMOSOME 1P36.3; COMPARATIVE STUDY; CONTROLLED STUDY; EGYPT; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE EXPRESSION; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; OVERALL SURVIVAL; ADOLESCENT; BIOSYNTHESIS; BONE MARROW; CHROMOSOME 1; CHRONIC HEPATITIS C; COMPLICATION; FEMALE; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL; TELOMERE; YOUNG ADULT;

ADOLESCENT; ADULT; BONE MARROW; CHROMOSOMES, HUMAN, PAIR 1; FEMALE; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KI-67 ANTIGEN; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; SEQUENCE DELETION; SURVIVAL ANALYSIS; TELOMERE; YOUNG ADULT;

EID: 84910607959     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12304     Document Type: Article

References (17)

1. Mrozek K, Bloomfield CD,. Cytogenetics of non-Hodgkin's lymphoma and Hodgkin's disease. In:, Wiernik PH, Canellos GP, Dutcher JP, Kyle RA, eds. Neoplastic Diseases of Blood, 3rd edn. New York: Churchill Livingstone, 1996: 835-862.
2. Ragnarsson G, Eiriksdottir G, Johannsdottir JT, et al,. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 1999; 79: 1468-1474.
3. Ping Siu LL, Cheung Chan JK, Wong KF, et al,. Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol 2002; 160: 59-66.
4. Pastuszewski W, Dziegiel P, Krecicki T, et al,. Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer. Anticancer Res 2007; 27: 335-342.
5. Rosenwald A, Ott G,. Burkitt lymphoma versus diffuse large B cell lymphoma. Ann Oncol 2008; 19 (Suppl 4): iv 67-9.
6. Otsuka M, Kato N, Lan K, et al,. Hepatitis C virus core protein enhances p53 function through augmentation of DNA binding affinity and transcriptional ability. J Biol Chem 2000; 275 (44): 34122-34130.
7. Giambartolomei S, Covone F, Levrero M, Balsano C,. Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein. Oncogene 2001; 20 (20): 2606-2610.
8. Gisbert JP, Garcia-Buey L, Pajares JM, et al,. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723-1732.
9. Trejo O, Ramos-Casals M, Lopez-Guillermo A, et al,. Henatologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases. Semin Arthritis Rheum 2003; 33: 19-28.
10. Zubrod CG, Ipsen J, Frei E, et al,. Newer techniques and some problems in cooperative group studies. Natl Cancer Inst Monogr 1960; 3: 277-292.
11. Coiffier B,. Non-Hodgkin's Lymphomas. In:, Cavalli F, Han Sen HH, Kaye SB, eds. " A Textbook of Medical Oncology ", 2nd edn. London: Martin Dutitz Ltd., 2003: 530-541.
12. Rajgopal A, Carr IM, Leek JP, et al,. Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis. Cancer Genet Cytogenet 2003; 142: 46-50.
13. Parkin DM,. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118 (12): 3030-3044.
14. Hoglund M, Sehn l, Connors JM, et al,. Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas. Genes Chromosom Cancer 2004; 39: 195-204.
15. Stoffel A, Filippa D, Rao PH,. The p73 locus is commonly deleted in non-Hodgkin's lymphomas. Leuk Res 2004; 28: 1341-1345.
16. Ross CW, Ouillette PD, Saddler CM, et al,. Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis. Clin Cancer Res 2007; 13: 4777-4785.
17. Smedley D, Sidhar S, Birdsall S, et al,. Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosom Cancer 2000; 28: 121-125.